Immune-Cell Numbers Determine Combination Immunotherapy Response in Melanoma Patients – AJMC.com Managed Markets Network
|
Immune-Cell Numbers Determine Combination Immunotherapy Response in Melanoma Patients
AJMC.com Managed Markets Network The Journal of Clinical Investigation Insight recently published a study that analyzed 112 different melanoma tumors in attempt to correlate partially exhausted cytotoxic lymphocytes (peCTLs) and regulatory T lymphocyte (Treg) levels with response to … |
